Literature DB >> 33050774

Joint analysis of recurrence and termination: A Bayesian latent class approach.

Zhixing Xu1, Debajyoti Sinha1, Jonathan R Bradley1.   

Abstract

Like many other clinical and economic studies, each subject of our motivating transplant study is at risk of recurrent events of non-fatal tissue rejections as well as the terminating event of death due to total graft rejection. For such studies, our model and associated Bayesian analysis aim for some practical advantages over competing methods. Our semiparametric latent-class-based joint model has coherent interpretation of the covariate (including race and gender) effects on all functions and model quantities that are relevant for understanding the effects of covariates on future event trajectories. Our fully Bayesian method for estimation and prediction uses a complete specification of the prior process of the baseline functions. We also derive a practical and theoretically justifiable partial likelihood-based semiparametric Bayesian approach to deal with the analysis when there is a lack of prior information about baseline functions. Our model and method can accommodate fixed as well as time-varying covariates. Our Markov Chain Monte Carlo tools for both Bayesian methods are implementable via publicly available software. Our Bayesian analysis of transplant study and simulation study demonstrate practical advantages and improved performance of our approach.

Entities:  

Keywords:  Bayesian analysis; frailty; intensity and rate; joint model; recurrent events

Mesh:

Year:  2020        PMID: 33050774      PMCID: PMC8009817          DOI: 10.1177/0962280220962522

Source DB:  PubMed          Journal:  Stat Methods Med Res        ISSN: 0962-2802            Impact factor:   3.021


  21 in total

1.  Shared frailty models for recurrent events and a terminal event.

Authors:  Lei Liu; Robert A Wolfe; Xuelin Huang
Journal:  Biometrics       Date:  2004-09       Impact factor: 2.571

2.  Disparities in solid organ transplantation for ethnic minorities: facts and solutions.

Authors:  R S D Higgins; J A Fishman
Journal:  Am J Transplant       Date:  2006-09-04       Impact factor: 8.086

3.  Parametric latent class joint model for a longitudinal biomarker and recurrent events.

Authors:  Jun Han; Elizabeth H Slate; Edsel A Peña
Journal:  Stat Med       Date:  2007-12-20       Impact factor: 2.373

4.  Current Methods for Recurrent Events Data with Dependent Termination: A Bayesian Perspective.

Authors:  Debajyoti Sinha; Tapabrata Maiti; Joseph G Ibrahim; Bichun Ouyang
Journal:  J Am Stat Assoc       Date:  2008-06-01       Impact factor: 5.033

5.  An estimating function approach to the analysis of recurrent and terminal events.

Authors:  John D Kalbfleisch; Douglas E Schaubel; Yining Ye; Qi Gong
Journal:  Biometrics       Date:  2013-05-07       Impact factor: 2.571

6.  Joint scale-change models for recurrent events and failure time.

Authors:  Gongjun Xu; Sy Han Chiou; Chiung-Yu Huang; Mei-Cheng Wang; Jun Yan
Journal:  J Am Stat Assoc       Date:  2017-04-12       Impact factor: 5.033

7.  A copula-based mixed Poisson model for bivariate recurrent events under event-dependent censoring.

Authors:  Richard J Cook; Jerald F Lawless; Ker-Ai Lee
Journal:  Stat Med       Date:  2010-03-15       Impact factor: 2.373

8.  Semiparametric transformation models with random effects for joint analysis of recurrent and terminal events.

Authors:  Donglin Zeng; D Y Lin
Journal:  Biometrics       Date:  2008-09-29       Impact factor: 2.571

9.  Recurrent event data analysis with intermittently observed time-varying covariates.

Authors:  Shanshan Li; Yifei Sun; Chiung-Yu Huang; Dean A Follmann; Richard Krause
Journal:  Stat Med       Date:  2016-02-16       Impact factor: 2.373

10.  Joint modelling of repeated measurements and time-to-event outcomes: flexible model specification and exact likelihood inference.

Authors:  Jessica Barrett; Peter Diggle; Robin Henderson; David Taylor-Robinson
Journal:  J R Stat Soc Series B Stat Methodol       Date:  2014-04-08       Impact factor: 4.488

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.